// App-Quantinova.ai

122 : Markers of Coagulation and Hemostatic Activation Identify Embolic Stroke of Undetermined Source (ESUS) Patients who are at Risk of Recurrent Thrombotic Events on Antiplatelet Therapy, A Validation Study

Researchers

Presenter

  • Vera Sharashidze

Principal Investigators

  • Srikant Rangaraju

  • Priyadharshi Rathakrishnan

  • Alexander Duncan

  • Michael Hoskins

  • Fahad Marmarchi

  • Samir Belagaje

  • Nicolas Bianchi

  • Trina Belair

  • Laura Henriquez

  • Kaslyn Monah

  • Fadi Nahab

Medical Centers

  • Emory University, Atlanta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Venous thrombosis

  • Stroke

Biomarkers

  • Fragment 1+2

Drug/Treatment

  • Hemostatic Solution

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved